Evidence map›Paper›PMID 34103343›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2021

Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases.

Christopher Grunseich, Nathan Sarkar, Joyce Lu, Mallory Owen, Alice Schindler, Peter A Calabresi, Charlotte J Sumner, Ricardo H Roda, Vinay Chaudhry, Thomas E Lloyd and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Genetic Sequencing in Saudi Patients with Systemic Lupus Erythematosus.Open access rheumatology : research and reviews · 2026
    Article
  3. Review
  4. A Spectrum of Pathogenic Variants in theInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Christopher GrunseichNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA christopher.grunseich@nih.gov ami.mankodi@nih.gov.ORCID 0000-0003-4994-2472
Nathan SarkarNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Joyce LuNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Mallory OwenNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Alice SchindlerNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Peter A CalabresiDepartments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-7776-6472
Charlotte J SumnerDepartments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5088-6012
Ricardo H RodaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-3255-7749
Vinay ChaudhryDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5625-7989
Thomas E LloydDepartments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-4756-3700
Thomas O CrawfordDepartments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0916-2797
S H SubramonyDepartment of Neurology, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-8052-9240
Shin J OhDepartment of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-7989-6107
Perry RichardsonDepartment of Neurology, George Washington University, Washington, District of Columbia, USA.
Kurenai TanjiDivision of Neuropathology, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0003-2230-2416
Justin Y KwanNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Kenneth H FischbeckNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Ami MankodiNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA christopher.grunseich@nih.gov ami.mankodi@nih.gov.ORCID 0000-0002-5131-7767
National Institutes of Health · USJohns Hopkins University · USColumbia University Irving Medical Center · USGeorge Washington University · USUniversity of Alabama at Birmingham · USUniversity of Florida · US

Funding

Hereditary Muscle Disease UnitZIANS003131 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI MANKODI, AMI · 2012 to 2023
$11.7M
Studies Of Hereditary Neurological Disease: Disease Gene IdentificationZIANS002974 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI FISCHBECK, KENNETH · 2009 to 2023
$9.8M
Imaging Neurodegeneration in Multiple SclerosisR01NS082347 · NINDS · JOHNS HOPKINS UNIVERSITY · PI PETER A CALABRESI, Shiv Saidha · 2013 to 2026
$7.0M
Intramural NIH HHS ZIA NS002974NINDS NIH HHS R01 NS082347
6 · The paper itself

Abstract

backgroundWe used a multimodal approach including detailed phenotyping, whole exome sequencing (WES) and candidate gene filters to diagnose rare neurological diseases in individuals referred by tertiary neurology centres.

methodsWES was performed on 66 individuals with neurogenetic diseases using candidate gene filters and stringent algorithms for assessing sequence variants. Pathogenic or likely pathogenic missense variants were interpreted using in silico prediction tools, family segregation analysis, previous publications of disease association and relevant biological assays.

resultsMolecular diagnosis was achieved in 39% (n=26) including 59% of childhood-onset cases and 27% of late-onset cases. Overall, 37% (10/27) of myopathy, 41% (9/22) of neuropathy, 22% (2/9) of MND and 63% (5/8) of complex phenotypes were given genetic diagnosis. Twenty-seven disease-associated variants were identified including ten novel variants in

conclusionsIntegrating deep phenotyping, gene filter algorithms and biological assays increased diagnostic yield of exome sequencing, identified novel pathogenic variants and extended phenotypes of difficult to diagnose rare neurogenetic disorders in an outpatient clinic setting.

Indexed as

Exome SequencingMutationAdolescentAdultAgedGenetic Diseases, InbornHumansMiddle AgedMolecular Diagnostic TechniquesNervous System DiseasesPedigreePhenotypeRare DiseasesYoung Adult

Identifiers

PMID34103343
PMCPMC8522445
OpenAlexW3169522697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.